INTRODUCTION
P rimary congenital glaucoma (PCG) is the most common childhood glaucoma accounting for 50%-70% of the cases [1] [2] [3] . It occurs due to the abnormal development of the trabecular meshwork (TM) and the anterior chamber angle. This anomaly is called trabeculodysgenesis or iridotrabeculodysgenesis according to the tissues involved [1, 4] . It is characterized by an elevation in intraocular pressure (IOP) in the early infantile period, which causes structural damage to the eyeball such as buphthalmos, corneal edema, Haab's striae and may result in optic nerve damage and subsequent permanent loss of vision [3, 5] . The combined trabeculotomytrabeculectomy procedure with mitomycin-C (MMC) was recommended as a primary procedure in moderate to severe cases [6] [7] . About 10%-40% of PCG cases are familial and may be associated with consanguinity [1, 8] . Its incidence varies geographically; PCG is four times more common in Saudi Arabia than in Western societies with an incidence of 1:2500 and 1:10 000 live births respectively [1, 3, 8] . Four different loci have been linked to PCG (GLC3A, GLC3B, GLC3C and GLC3D) [8] [9] [10] [11] [12] . Mutations in the cytochrome P4501B1 gene (CYP1B1) located in the GLC3A locus on chromosome 2p21 are the most predominant (Online Mendelian Inheritance in Man, OMIM, ID No.231300). They were first reported in PCG patients in 1997 [13] .
Sequence analyses have so far revealed approximately 243 different mutations in the CYP1B1 gene (Human Genome Mutation database; http://www.hgmd.cf.ac.uk/ac/index.php), of which about 159 are implicated in the pathogenesis of PCG which indicates excessive allelic heterogeneity [11, [14] [15] . The mutation spectra of CYP1B1 varies widely across different populations [15] ; from almost 100% among Saudi Arabians [16] and Slovakian Gypsies [17] , to 50% among Brazilians, and 20% in Japanese [13, [18] [19] . It was found that patients with CYP1B1
gene mutations required more surgeries to control the IOP than patients without these mutations [20] [21] . Very little investigation has been done to study CYP1B1 and PCG in Egyptian patients. In this work, we perform a preliminary investigation to identify CYP1B1 mutations in PCG Egyptian patients and to evaluate the role of CYP1B1 mutations as a prognostic factor predicting the outcome of surgery in a cohort group of Egyptian PCG patients operated on with combined trabeculotomy-trabeculectomy with MMC.
SUBJECTS AND METHODS
Ethical Approval This prospective interventional study was approved by the Research Ethics Committee of Cairo University Hospitals and the declaration of Helsinki was respected. Subjects for the study were recruited randomly from the patients attending the Cairo University Pediatric Ophthalmology clinic who met the inclusion criteria for the study. All parents of patients signed an informed consent for the surgery and inclusion in the study. Patients Inclusion criteria entailed being an Egyptian primary congenital glaucoma patient who was not operated on before in at least one eye and age of onset ranging from 0-2y. Secondary glaucoma patients and patients having additional developmental ocular and/or systemic anomalies were excluded from the study. Surgical Procedure The patients were subjected to full ophthalmic assessment to confirm meeting the inclusion criteria, including detailed anterior segment examination with measurement of the horizontal corneal diameter, measurement of the IOP using Perkins applanation tonometer under general anesthesia, posterior segment evaluation (by ophthalmoscopy or ultrasonography), and axial length measurement. The clinical severity of the cases was assessed using a severity scale of mild, moderate and severe as proposed earlier [6] .
Children meeting the inclusion criteria underwent combined trabeculectomy-trabeculotomy with MMC done by the same surgeon in all patients. Postoperatively, the patients underwent full ophthalmic assessment (under sedation with oral chloral hydrate 25 mg/kg, once, 30min prior to examination) at one day, one week, and then monthly for one year including measurement of IOP, horizontal corneal diameter, and optic nerve head evaluation. Surgical result of the initial operation was graded into either success (maintaining IOP less than 21 mm Hg with or without anti-glaucoma medication at the end of the follow-up period), or failure (IOP more than 21 mm Hg with topical antiglaucoma medications at any point during the follow-up period). CYP1B1 Gene Mutation Detection Peripheral blood samples were collected, at the time of the initial procedure, and genomic DNA was extracted using Generation capture column kit (Gentra, USA) following the manufacturer's protocol. The coding regions in CYP1B1 were amplified using 13 pairs of primers from a previous study [22] . Polymerase chain reaction (PCR) amplification of the coding regions of the CYP1B1 gene from genomic DNA and screening with single-strand conformation polymorphism (SSCP) were performed as previously described [22] . Ltd., San Francisco, USA). Evolutionary conserved regions were studied by comparing amino acid sequences across different species (obtained from NCBI). The impact of missense mutations was predicted by using the mutationtolerance-prediction software (SIFT) provided by Genome Institute of Singapore, available on the website (http://sift. bii.astar.edu.sg/). Patients with confirmed CYP1B1 sequence alteration were designated "mutation-present", while those who could not be confirmed with sequence alteration were designated "mutation-absent". Statistical Analysis All statistical analyses were done using IBM SPSS v20.0 software (IBM Corporation, USA). Descriptive statistics were calculated, and the data were summarized as mean±standard deviation (SD) for continuous variables. Percentages and tables were used to describe categorical data. Comparisons between categorical data were done using Pearson's Chi-square test or Fisher's exact test. Comparisons of non-paired continuous variables were done using independent samples t-test, while comparisons of paired continuous variables were carried out using paired sample t-test. Correlations between non-parametric variables were done by Spearman's rank correlation coefficient. Cumulative success of the initial procedure between both groups was examined using Kaplan-Meier survival analysis. A P-value <0.05 was considered statistically significant.
RESULTS Patients Data
The study included 42 eyes in 29 Egyptian children who underwent combined trabeculotomy-trabeculectomy with MMC as an initial procedure and were followed-up for 12mo postoperatively. Table 1 summarizes the demographic data collected from the 42 eyes (29 patients) included in the study. The mean age at presentation of the 29 patients was 8.57±10.63mo. No difference was found in clinical severity between the two subgroups in our study (Table 2) . Table 3 shows the summary of the preoperative and postoperative IOP and corneal diameter of the 42 eyes included in the study. Table 4 ). Eight of these alterations were previously reported in different populations (HGMD; http:// www.hgmd.cf.ac.uk/); three were previously reported SNP (3793 C>T, R48G, and D449D). Seven were novel mutations of which only 2 were predicted to be tolerated [4054 C>G (D83E) and 4535 A>C (M244L)], and the remaining 5 were suggested to be damaging mutation according to "Tolerance Simulation on SIFT". The novel mutation 4545insC resulted in terminating the protein at amino acid 326 eliminating exon 3 from the resulting truncated protein. All patients with novel mutations had more than one mutation except for patient 14 who had only 4545insC (Ter@326) chain termination mutation. The mutation most frequently found in this study is the previously reported damaging mutation G61E which was found in 5 patients. Most of the mutated amino acids lie in areas that are evolutionary conversed as shown in Figure 1C .
The genotype-phenotypes encountered in our study are summarized in Tables 5 and 6. Table 5 shows the 14 patients identified with different mutations. A wide variability in phenotype is noticed with all mutations. From Table 6 , it is clear that mutations with severe phenotype and bad outcome were G61E, the truncating mutation Y81X and the frameshift 4339delG. One patient was homozygous while the other had compound heterozygous genotype (G61E+G211D). All these mutations were reported previously with severe phenotypes and bad prognosis [19] . Thirty-one eyes (76%) in 22 patients showed success, while eleven eyes (24%) in 7 patients showed failure of the initial procedure and required re-surgery. Five out of 7 patient with failed initial procedure had confirmed mutations. While 9 out of 22 patients with successful initial procedure had mutations (Table 7) . Positive consanguinity was found to be strongly correlated to failure of the initial procedure (P=0.016) with an odds ratio of 11.25 (Table 7 ). Age at presentation was found to have a significant directly proportional correlation with survival time, i.e. the older the child, the longer the initial procedure controls the IOP (rho=0.542, P<0.001). A weaker inverse relationship (rho=-0.332, P=0.031) was present between initial IOP and the survival time (Table 8) . KaplanMeier survival analysis was done to compare the survival time between the mutation-present and the mutation-absent subgroups a difference was revealed in favor of mutationabsent subgroup (Figure 2) . This difference was found to be highly significant (log-rank test, P=0.015). [23] , 1998 (rs1056837) SNP: Single nucleotide polymorphism. 
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DISCUSSION
PCG is the most common childhood glaucoma. Despite being rare, its occurrence increases 10 times in some parts of the world because of consanguinity [28] . It has been repeatedly found that mutations in CYP1B1 are involved in the development of the disease. Mutations of this gene have not been properly analyzed in Egypt. In this study, we presented the association between mutations of the CYP1B1 gene and the failure of surgery in PCG. It was found that patients with confirmed CYP1B1 mutations were more likely to fail their initial surgical procedure earlier than patients without mutations as shown from the survival analysis of the surgeries done to the patients enrolled in the study. Based on Al-Hazmi et al [6] , 2005. The mechanism by which CYP1B1 mutations cause the disease is not fully understood [29] . However, it is hypothesized that these mutations result in either reduced activity or abundance of the CYP1B1 enzyme or both [30] . G61E mutation may be implicated with reduced activity, while frameshift mutations and Y81X mutation can result in a decreased abundance of the protein [30] . The reduction or absence of the cytochrome p450 enzyme 1B1 may affect the spatial and temporal regulation of the development of the anterior chamber angle or lead to arrest of its development through accumulation of toxic metabolites [31] . Hollander et al [32] in 2006 studied a small group of PCG patients and classified their angle anomalies histologically into three categories and tried to correlate it with the severity of the disease and the detected CYP1B1 mutations. His work highlighted the possibility that CYP1B1 mutations affect the severity of the disease through affecting the severity of the induced angle anomalies. Few studies addressed the association of CYP1B1 mutations with poor surgical prognosis in PCG [3, [20] [21] [33] [34] . Della Paolera et al [20] in 2010 reported that Brazilian patients with CYP1B1
mutations required significantly more surgical procedures to control the IOP than those without mutations. The same finding was reported in a group of Arab and Jewish patients [21] . However, in both of these studies, the surgical procedures performed for the patients were not identified. Chakrabarti et al [33] in 2010 analyzed a CYP1B1 promoter polymorphism and studied the survival of IOP control in patients with or without mutations and found a significant difference between the two groups. The mutation group had poorer control of the IOP over the postoperative period of follow-up. These results are in agreement with the current study in which the initial procedure had more tendencies to fail early in the group with confirmed mutations. Abu-Amero et al [3] in 2011 studied a group of 74 eyes of Saudi patients with PCG. They reported a non-significant correlation between success or failure of the surgery with the mutation status. These results are in contrast with the results of the current study. This may be attributed to the fact that their patients were operated without randomization using two different surgical procedures; namely combined trabeculectomy-trabeculotomy and nonpenetrating deep sclerectomy with adjuvant MMC. The later procedure is usually inadequate in presence of an anomalous angle [35] . The success rate of the first procedure in Middle Eastern PCG patients (66%) is lower than Western PCG patients (80%-90%) [36] . Geyer et al [21] in 2011 noticed that Jewish PCG patients of European descent had a milder form of the disease and required lesser number of procedure to control the IOP than Arabs and Druze PCG patients. They related this to the lower incidence of CYP1B1 mutations detected in the group of Jewish patients than the other two groups in the study. The success rate in our study was 69% which is comparable to the results reported by Mullaney et al [7] in 1999 and Al-Hazmi et al [6] in 2005 for combined trabeculotomy-trabeculectomy with MMC in moderate to severe cases (70%-80%). Both studies were carried on Saudi patients who are close in ethnicity to our group of patients. Overview of the factors related to the success and failure of the surgical procedure in our group revealed that positive consanguinity was significantly associated with more failure of the initial procedure. Furthermore, presence of CYP1B1 mutations, early age at presentation and high initial IOP were all associated with the lower survival and early failure of the initial procedure. In our cohort, the younger the patient at the initial diagnosis, the higher his presenting IOP and the earlier he might fail the surgery. The early onset and onset at birth has been always related to the poor outcome of the surgery [37] [38] [39] . However, in 2005, Levy et al [36] underwent a study of prognostic factors for PCG operated in the first 3mo of life in Arab Bedouins. They found that their failure group had significantly higher initial IOP than the successful group, otherwise no other factors; such as mean age at presentation or corneal diameter, was associated with the final outcome. They proposed that initial IOP could be the prognostic factor for the final outcome in PCG. High presenting IOP is considered a severe phenotype that has been associated with presence of CYP1B1 mutations in PCG patients [29, 40] . From our results, patients with CYP1B1 mutations were more likely to have lower survival time for the first procedure than the other patients. The patients with mutations had distorted Vol. 12, No. 4, Apr.18, 2019 www.ijo.cn Tel: 8629-82245172 8629-82210956 Email: ijopress@163.com anatomy at the area of the corneoscleral limbus, which made the identification of Schlemm's canal more difficult and the surgeon noticed increased resistance to the trabeculotome insertion into the canal in this group than the non-mutation group of patients. This observation may signal an under-or abnormal development of Schlemm's canal in these patients. These findings suggest that presence of CYP1B1 could be considered as a prognostic factor for the outcome of the surgery, along with clinical prognostic factors such as poor corneal clarity, high presenting IOP and early onset of the disease. This is especially important in populations with high incidence of CYP1B1 mutations as in the Middle East and India. Belmouden et al [26] in 2002 and Abu-Amero et al [3] in 2011 proposed screening for the founder mutation, G61E, in PCG patients from Middle Eastern descent due to its high prevalence. However, all sequence alterations of CYP1B1 should be considered.
A limitation of this study may be the small sample size, but the controlled nature of this prospective study compensated for this weakness. All patients were chosen with the same criteria and from the Egyptian population only. In addition, they were operated upon with the same procedure, done by the same surgeon in all patients. This prospective cohort controlled study design is the best to evaluate risk factors and their impact on the natural history of the disease or intervention [41] . The lack of normal control for CYP1B1 mutations and SNPs in the Egyptian population is another limitation, but we compensated for this by comparative sequence alignment with other CYP1B1 orthologous proteins and computer-assisted mutation tolerance simulation. None the less, the screening for SNPs in normal Egyptian population should be considered in further studies. In addition, the presence of compound mutations makes it harder to identify the phenotypic outcome associated with a specific mutation without further investigations. In summary, this study suggests that CYP1B1 mutations participate in the development of primary congenital glaucoma in Egyptian patients. Seven novel CYP1B1 mutations were detected in our group that could be specific to the Egyptian population. Five of these were suggested to be damaging mutations according to "Tolerance Simulation on SIFT". The novel mutation 4545insC resulted in terminating the protein at amino acid 326 eliminating exon 3 from the protein.
Further studies are required to determine the effects of these mutations on the function of the protein and consequently the possible role in the development of PCG. On the other hand, G61E mutation was the most frequently encountered in our group with potential adverse effects on the clinical severity and surgical prognosis of PCG. Patients harboring CYP1B1 mutations suffer from early failure and poorer prognosis than patients with no mutations of CYP1B1. Therefore, CYP1B1 mutations might be considered as a prognostic factor for the surgery in PCG together with clinical prognostic factors. From the outcomes of the current research, we recommend that at least patients with severe phenotype should undergo genetic testing which will give a good prognostic idea regarding the outcomes of their subsequent surgery.
